These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 9376555)
1. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors]. Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555 [TBL] [Abstract][Full Text] [Related]
2. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem]. Vogl TJ; Hammerstingl R; Keck H; Felix R Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
4. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Lee JM; Kim CS; Youk JH; Lee MS Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629 [TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media]. Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451 [TBL] [Abstract][Full Text] [Related]
6. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899 [TBL] [Abstract][Full Text] [Related]
7. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules. Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity. Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487 [TBL] [Abstract][Full Text] [Related]
9. [T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients]. Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny EJ; Shamsi K; Balzer T; Peters PE Rofo; 1998 Mar; 168(3):228-36. PubMed ID: 9551108 [TBL] [Abstract][Full Text] [Related]
10. [New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors]. Daldrup HE; Reimer P; Rummeny EJ; Tombach B; Berns T; Balzer T; Schimpfky C; Peters PE Radiologe; 1995 Aug; 35(8):486-93. PubMed ID: 7568792 [TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017 [TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images. Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695 [TBL] [Abstract][Full Text] [Related]
16. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence. Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042 [TBL] [Abstract][Full Text] [Related]
17. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106 [TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887 [TBL] [Abstract][Full Text] [Related]
19. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors. Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744 [TBL] [Abstract][Full Text] [Related]
20. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?]. Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]